Dr. Jeffrey Herschel Levenson, MD

Dr. Levenson practices at Riverside Park Surgicenter in Jacksonville, Florida.

Dr. Levenson's NPI, 1023118379, was assigned on September 25, 2006. Dr. Levenson graduated from University Of Florida College Of Medicine in 1984. Dr. Levenson holds Florida license ME0052225.

Dr. Levenson's primary practice is Riverside Park Surgicenter, at 2001 College Street, Jacksonville, FL 32204. The practice phone is (904) 355-9800.

Dr. Levenson's primary practice is Riverside Park Surgicenter in Jacksonville, Florida. Dmand AI also links Dr. Levenson to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levenson practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Levenson's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Levenson is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Levenson's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Levenson treats.

CMS data shows 5,158 Medicare services from Dr. Levenson across 21 procedure codes in 2024, for 1,857 Medicare patients. Medicare paid $444,616 for them.

CMS counts 1,857 Medicare patients who saw Dr. Levenson in 2024. The largest group is 75 to 84, with 858 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Levenson's median patient age at 74, with 60% women.

In 2024, Dr. Levenson wrote 10,579 Medicare Part D claims for 2,570 patients. 65% of them were for generic drugs. CMS names the drug for 10,357 of them, across 37 drugs with 11 or more claims each, at $922,911 in total drug cost. In 2023, CMS named 10,342 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Levenson for performance year 2024, reported individually. Dr. Levenson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 323 procedures of cataract surgery by Dr. Levenson, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Levenson in 2014. Dr. Levenson's most frequent co-authors are Samuel Masket, MD, Thomas Robert Elmer, MD and William Montgomery Flynn, MD.

Dmand AI links Dr. Levenson to 1 clinical trial. Conditions studied include Corneal Endothelial Cell Loss and Eye Pain.

CMS Open Payments shows 343 general payments to Dr. Levenson from 41 drug and device companies from 2016 to 2025. Charitable contributions make up the largest share, 50% of the total. Valeant Pharmaceuticals International paid the most, $18,593. It also lists 45 research payments totaling $415,816 from 2016 to 2022.

Dmand AI lists 8 awards for Dr. Levenson, most recently Operation Sight Volunteer of the Year Award in 2022.

Dr. Levenson graduated from University Of Florida College Of Medicine in 1984. Dr. Levenson is a member of AAO.

Dr. Levenson is in network with 14 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.